Case Series of Anesthetic Management of Gene Therapy in Children With Aromatic L‐Amino Acid Decarboxylase Deficiency
Pediatric Anesthesia · 2025
DOI: 10.1111/pan.15060 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pediatric Anesthesia, 2025. Verfasst von Simon Clariot und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology, Adolphe de Rothschild Foundation Hospital, Paris, France. Hauptthemen laut MEDLINE: Amino Acid Metabolism, Inborn Errors, Anesthesia, General, Aromatic-L-Amino-Acid Decarboxylases, Genetic Therapy. Die Arbeit nennt 13 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Aromatic L‐amino acid decarboxylase (AADC) deficiency is a rare life‐threatening inborn error of neurotransmitter biosynthesis. It is characterized by deficient biosynthesis of neurotransmitters dopamine and serotonin, leading to catecholamines deficiency and sympathetic deprivation, while the parasympathetic system remains functional. Since 2012, gene therapy has led to clinical improvements in symptoms and motor function with a severe phenotype. General anesthesia of children with AADC deficiency is challenging.
Aim
Describe prolonged anesthesia management of children with aromatic L‐amino acid decarboxylase deficiency undergoing stereotactically guided gene therapy.
Methods
Prospective reporting of epidemiologic and anesthetics data of four children consecutively undergoing magnetic resonance‐guided direct delivery of an AADC vector for gene therapy under general anesthesia.
Results
General anesthesia was initiated with sevoflurane and ketamine and rocuronium was the neuromuscular blocking agent of choice throughout the procedures. Intraoperative hemodynamic monitoring included an arterial line. All children required low doses of diluted norepinephrine during the intraoperative period. No dysautomic episodes as well as no episode of severe hypotension and no severe hypoglycemia were reported throughout the procedures. Vasopressor support was discontinued for all children at the end of the procedures. Moreover, no peroperative and postoperative effects secondary to AADC vector injection were noted.
Conclusion
Using an anesthetic plan based on atropine, ketamine, sevoflurane, and a titrated infusion of norepinephrine, prolonged anesthesia appeared to be safe and reproductible in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anaesthesiology, Adolphe de Rothschild Foundation Hospital, Paris, France.
- DYSPA Unit, Adolphe de Rothschild Foundation Hospital, Paris, France.
- Department of Pediatric Neurosurgery, Adolphe de Rothschild Foundation Hospital, Paris, France.
- Department of Pediatric Neurology, Trousseau Hospital, Paris, France.
ORCID-Profile: Simon Clariot
Zitieren
APA
Clariot, S., Gras, S., Goetz, L., Boulloud, C., Bonheur, J., Vayssiere, P., D'Hardemare, V., Ravelli, C., Dorison, N., & Devys, J. M. (2025). Case Series of Anesthetic Management of Gene Therapy in Children With Aromatic L‐Amino Acid Decarboxylase Deficiency. Pediatric Anesthesia. https://doi.org/10.1111/pan.15060
Vancouver
Clariot S, Gras S, Goetz L, Boulloud C, Bonheur J, Vayssiere P, et al. Case Series of Anesthetic Management of Gene Therapy in Children With Aromatic L‐Amino Acid Decarboxylase Deficiency. Pediatric Anesthesia. 2025. doi:10.1111/pan.15060
BibTeX
@article{Clariot2025,
author = {Clariot, Simon and Gras, Séverine and Goetz, Laurent and Boulloud, Christophe and Bonheur, Julie and Vayssiere, Pia and D'Hardemare, Vincent and Ravelli, Claudia and Dorison, Nathalie and Devys, Jean-Michel},
title = {Case Series of Anesthetic Management of Gene Therapy in Children With Aromatic L‐Amino Acid Decarboxylase Deficiency},
journal = {Pediatric Anesthesia},
year = {2025},
doi = {10.1111/pan.15060}
}
EUVIMED